Abuse Deterrent Pharma, LLC 4
4 · ACURA PHARMACEUTICALS, INC · Filed Jun 28, 2021
Insider Transaction Report
Form 4
Abuse Deterrent Pharma, LLC
10% Owner
Transactions
- Conversion
Convertible Promissory Note
2021-06-09−6,877,500→ 0 totalExercise: $0.16From: 2019-06-28→ Common Stock (42,984,375 underlying) - Conversion
Common Stock
2021-06-09$0.16/sh+42,984,375$6,877,500→ 42,984,375 total
Holdings
- 1,782,531
Warrant to Purchase Common Stock
Exercise: $0.53From: 2017-07-24Exp: 2022-07-23→ Common Stock (1,782,531 underlying)
Footnotes (2)
- [F1]The note bears interest at the rate of 7.5% per annum. On the conversion date, all principal and $877,500 of interest under the note was converted into the Issuer's common stock. For each $0.16 converted, AD Pharma received one share of common stock.
- [F2]This note is convertible, at the election of AD Pharma, at any time prior to repayment of the note and matures on July 1, 2023.